|
1
|
Spady TJ, McComb RD and Shull JD: Estrogen
action in the regulation of cell proliferation, cell survival, and
tumorigenesis in the rat anterior pituitary gland. Endocrine.
11:217–233. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yue W, Yager JD, Wang JP, Jupe ER and
Santen RJ: Estrogen receptor-dependent and independent mechanisms
of breast cancer carcinogenesis. Steroids. 78:161–170. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nandi S, Guzman RC and Yang J: Hormones
and mammary carcinogenesis in mice, rats, and humans: A unifying
hypothesis. Proc Natl Acad Sci USA. 92:pp. 3650–3657. 1995;
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seegers JC, Aveling ML, van Aswegen CH,
Cross M, Koch F and Joubert WS: The cytotoxic effects of
estradiol-17 beta, catecholestradiols and methoxyestradiols on
dividing MCF-7 and HeLa cells. J Steroid Biochem. 32:797–809. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu BT and Conney AH: Is
2-methoxyestradiol an endogenous estrogen metabolite that inhibits
mammary carcinogenesis? Cancer Res. 58:2269–2277. 1998.PubMed/NCBI
|
|
6
|
Lakhani NJ, Sarkar MA, Venitz J and Figg
WD: 2-Methoxyestradiol, a promising anticancer agent.
Pharmacotherapy. 23:165–172. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carothers AM, Hughes SA, Ortega D and
Bertagnolli MM: 2-Methoxyestradiol induces p53-associated apoptosis
of colorectal cancer cells. Cancer Lett. 187:77–86. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee YM, Ting CM, Cheng YK, Fan TP, Wong
RN, Lung ML and Mak NK: Mechanisms of 2-methoxyestradiol-induced
apoptosis and G2/M cell-cycle arrest of nasopharyngeal carcinoma
cells. Cancer Lett. 268:295–307. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L, Bu S, Bäckström T, Landström M,
Ulmsten U and Fu X: Induction of apoptosis and G2/M arrest by
2-methoxyestradiol in human cervical cancer HeLaS3 cells.
Anticancer Res. 24:873–880. 2004.PubMed/NCBI
|
|
10
|
Seeger H, Wallwiener D, Kraemer E and
Mueck AO: Comparison of possible carcinogenic estradiol
metabolites: Effects on proliferation, apoptosis and metastasis of
human breast cancer cells. Maturitas. 54:72–77. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Minorics R, Bózsity N, Molnár J, Wölfling
J, Mernyák E, Schneider G, Ocsovszki I and Zupkó I: A molecular
understanding of D-homoestrone-induced G2/M cell cycle arrest in
HeLa human cervical carcinoma cells. J Cell Mol Med. 19:2365–2374.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang I, Majid S, Saini S, Zaman MS,
Yamamura S, Chiyomaru T, Shahryari V, Fukuhara S, Deng G, Dahiya R
and Tanaka Y: Hrk mediates 2-methoxyestradiol-induced mitochondrial
apoptotic signaling in prostate cancer cells. Mol Cancer Ther.
12:1049–1059. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Siebert AE, Sanchez AL, Dinda S and
Moudgil VK: Effects of estrogen metabolite 2-methoxyestradiol on
tumor suppressor protein p53 and proliferation of breast cancer
cells. Syst Biol Reprod Med. 57:279–287. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Codogno P and Meijer AJ: Autophagy and
signaling: Their role in cell survival and cell death. Cell Death
Differ. 12 Suppl 2:S1509–S1518. 2005. View Article : Google Scholar
|
|
15
|
Debatin KM and Krammer PH: Death receptors
in chemotherapy and cancer. Oncogene. 23:2950–2966. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maiuri MC, Zalckvar E, Kimchi A and
Kroemer G: Self-eating and self-killing: Crosstalk between
autophagy and apoptosis. Nat Rev Mol Cell Biol. 8:741–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eisenberg-Lerner A, Bialik S, Simon HU and
Kimchi A: Life and death partners: Apoptosis, autophagy and the
cross-talk between them. Cell Death Differ. 16:966–975. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chuang TD, Ho M and Khorram O: The
regulatory function of miR-200c on inflammatory and cell-cycle
associated genes in SK-LMS-1, a leiomyosarcoma cell line. Reprod
Sci. 22:563–571. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
D'Angelo E and Prat J: Uterine sarcomas: A
review. Gynecol Oncol. 116:131–139. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Segars JH, Parrott EC, Nagel JD, Guo XC,
Gao X, Birnbaum LS, Pinn VW and Dixon D: Proceedings from the third
national institutes of health international congress on advances in
uterine leiomyoma research: Comprehensive review, conference
summary and future recommendations. Hum Reprod Update. 20:309–333.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reichardt P: The treatment of uterine
sarcomas. Ann Oncol. 23 Suppl 10:x151–x157. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee HG, Baek JW, Shin SJ, Kwon SH, Cha SD,
Park WJ, Chung R, Choi ES, Lee GH and Cho CH: Antitumor effects of
flavopiridol on human uterine leiomyoma in vitro and in a xenograft
model. Reprod Sci. 21:1153–1160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oltvai ZN, Milliman CL and Korsmeyer SJ:
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell death. Cell. 74:609–619. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rudel T: Caspase inhibitors in prevention
of apoptosis. Herz. 24:236–241. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Amaral JD, Xavier JM, Steer CJ and
Rodrigues CM: The role of p53 in apoptosis. Discov Med. 9:145–152.
2010.PubMed/NCBI
|
|
26
|
Deng X, Kornblau SM, Ruvolo PP and May WS
Jr: Regulation of Bcl2 phosphorylation and potential significance
for leukemic cell chemoresistance. J Natl Cancer Inst Monogr.
30–37. 2001.PubMed/NCBI
|
|
27
|
Gao N, Rahmani M, Dent P and Grant S:
2-Methoxyestradiol-induced apoptosis in human leukemia cells
proceeds through a reactive oxygen species and Akt-dependent
process. Oncogene. 24:3797–3809. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kondo Y and Kondo S: Autophagy and cancer
therapy. Autophagy. 2:85–90. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Salama SA, Nasr AB, Dubey RK and Al-Hendy
A: Estrogen metabolite 2-methoxyestradiol induces apoptosis and
inhibits cell proliferation and collagen production in rat and
human leiomyoma cells: A potential medicinal treatment for uterine
fibroids. J Soc Gynecol Investig. 13:542–550. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Robboy SJ, Bentley RC, Butnor K and
Anderson MC: Pathology and pathophysiology of uterine smooth-muscle
tumors. Environ Health Perspect. 108 Suppl 5:S779–S784. 2000.
View Article : Google Scholar
|
|
31
|
Walker CL and Stewart EA: Uterine
fibroids: The elephant in the room. Science. 308:1589–1592. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Akhan SE, Yavuz E, Tecer A, Iyibozkurt CA,
Topuz S, Tuzlali S, Bengisu E and Berkman S: The expression of
Ki-67, p53, estrogen and progesterone receptors affecting survival
in uterine leiomyosarcomas. A clinicopathologic study. Gynecol
Oncol. 99:36–42. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Reed JC, Talwar HS, Cuddy M, Baffy G,
Williamson J, Rapp UR and Fisher GJ: Mitochondrial protein p26 BCL2
reduces growth factor requirements of NIH3T3 fibroblasts. Exp Cell
Res. 195:277–283. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Joubert A, Maritz C and Joubert F:
Bax/Bcl-2 expression levels of 2-methoxyestradiol-exposed
esophageal cancer cells. Biomed Res. 26:131–134. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fukui M and Zhu BT: Mechanism of
2-methoxyestradiol-induced apoptosis and growth arrest in human
breast cancer cells. Mol Carcinog. 48:66–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
LaVallee TM, Zhan XH, Johnson MS,
Herbstritt CJ, Swartz G, Williams MS, Hembrough WA, Green SJ and
Pribluda VS: 2-methoxyestradiol up-regulates death receptor 5 and
induces apoptosis through activation of the extrinsic pathway.
Cancer Res. 63:468–475. 2003.PubMed/NCBI
|
|
37
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Meloche S and Pouysségur J: The ERK1/2
mitogen-activated protein kinase pathway as a master regulator of
the G1- to S-phase transition. Oncogene. 26:3227–3239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen JR, Plotkin LI, Aguirre JI, Han L,
Jilka RL, Kousteni S, Bellido T and Manolagas SC: Transient versus
sustained phosphorylation and nuclear accumulation of ERKs underlie
anti-versus pro-apoptotic effects of estrogens. J Biol Chem.
280:4632–4638. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tsai SC, Huang WW, Huang WC, Lu CC, Chiang
JH, Peng SF, Chung JG, Lin YH, Hsu YM, Amagaya S and Yang JS:
ERK-modulated intrinsic signaling and G(2)/M phase arrest
contribute to the induction of apoptotic death by allyl
isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells. Int
J Oncol. 41:2065–2072. 2012.PubMed/NCBI
|
|
41
|
Tang D, Wu D, Hirao A, Lahti JM, Liu L,
Mazza B, Kidd VJ, Mak TW and Ingram AJ: ERK activation mediates
cell cycle arrest and apoptosis after DNA damage independently of
p53. J Biol Chem. 277:12710–12717. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hemmings BA: Akt signaling: Linking
membrane events to life and death decisions. Science. 275:628–630.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cagnol S and Chambard JC: ERK and cell
death: Mechanisms of ERK-induced cell death-apoptosis, autophagy
and senescence. FEBS J. 277:2–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cheng Y, Qiu F, Tashiro S, Onodera S and
Ikejima T: ERK and JNK mediate TNFalpha-induced p53 activation in
apoptotic and autophagic L929 cell death. Biochem Biophys Res
Commun. 376:483–488. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lee JS, Kim YK, Yang H, Kang HY, Ahn C and
Jeung EB: Two faces of the estrogen metabolite 2-methoxyestradiol
in vitro and in vivo. Mol Med Rep. 12:5375–5382. 2015.PubMed/NCBI
|
